Vilin Bio Med Limited (NSE:VILINBIO)

India · Delayed Price · Currency is INR

46.50

+0.50 (1.09%)

Jul 13, 2026, 2:35 PM IST

80.58% (1Y)

Market Cap	648.68M +148.7%
Revenue (ttm)	422.63M +185.4%
Net Income	19.29M +763.0%
EPS	1.37 +756.3%
Shares Out	13.95M
PE Ratio	33.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Open	46.00
Previous Close	46.00
Day's Range	46.00 - 47.00
52-Week Range	18.95 - 54.40
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Vilin Bio Med

Vilin Bio Med Limited engages in the manufacture and trade of pharmaceutical products in India. It provides cardiovascular, musculo-skeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system and anti-allergic, anti- diabetic, liquid orals, and miscellaneous drugs, as well as multi-vitamins, minerals, and amino acids supplements. The company offers its products in the form of oral liquids, dry syrups, sachets, external preparations, beta and non beta lactam tablets and capsules, and nutritional food... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 2005

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol VILINBIO

Full Company Profile

Financial Performance

In fiscal year 2026, Vilin Bio Med's revenue was 422.63 million, an increase of 185.37% compared to the previous year's 148.10 million. Earnings were 19.29 million, an increase of 763.00%.

Financial Statements